Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer
- 15 March 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (6), 2349-2357
- https://doi.org/10.1158/0008-5472.can-08-2902
Abstract
The p53 protein is critical for multiple cellular functions including cell growth and DNA repair. We assessed whether polymorphisms in the region encoding TP53 were associated with risk of invasive ovarian cancer. The study population includes a total of 5,206 invasive ovarian cancer cases (2,829 of which were serous) and 8,790 controls from 13 case-control or nested case-control studies participating in the Ovarian Cancer Association Consortium (OCAC). Three of the studies performed independent discovery investigations involving genotyping of up to 23 single nucleotide polymorphisms (SNP) in the TP53 region. Significant findings from this discovery phase were followed up for replication in the other OCAC studies. Mixed effects logistic regression was used to generate posterior median per allele odds ratios (OR), 95% probability intervals (PI), and Bayes factors (BF) for genotype associations. Five SNPs showed significant associations with risk in one or more of the discovery investigations and were followed up by OCAC. Mixed effects analysis confirmed associations with serous invasive cancers for two correlated (r2 = 0.62) SNPs: rs2287498 (median per allele OR, 1.30; 95% PI, 1.07–1.57) and rs12951053 (median per allele OR, 1.19; 95% PI, 1.01–1.38). Analyses of other histologic subtypes suggested similar associations with endometrioid but not with mucinous or clear cell cancers. This large study provides statistical evidence for a small increase in risk of ovarian cancer associated with common variants in the TP53 region. [Cancer Res 2009;69(6):2349–57]Keywords
Other Versions
This publication has 44 references indexed in Scilit:
- Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological CharacteristicsPLoS Genetics, 2008
- Consortium analysis of 7 candidate SNPs for ovarian cancerInternational Journal of Cancer, 2008
- Association of Single Nucleotide Polymorphisms in Glycosylation Genes with Risk of Epithelial Ovarian CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancerInternational Journal of Cancer, 2007
- Relation of Contraceptive and Reproductive History to Ovarian Cancer Risk in Carriers and Noncarriers of BRCA1 Gene MutationsAmerican Journal of Epidemiology, 2004
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- The International HapMap ProjectNature, 2003
- Bayes FactorsJournal of the American Statistical Association, 1995
- Bayes FactorsJournal of the American Statistical Association, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986